Onconetix (ONCO) Revenue & Quarterly History
Explore Onconetix, Inc. (ONCO) revenue from 2023 through the latest reported quarter, with SEC-sourced comparisons and filing-constrained analysis.
Key takeaway
Quarter ended Mar 31, 2026 · FY2026 Q1
Revenue declined sharply in the current quarter. The decrease was steeper than both the prior quarter and the same quarter last year.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$21.5K
Revenue reported for this quarter.
Quarter-over-quarter
-92.9%
Change from the immediately preceding quarter.
Year-over-year
-78.9%
Change from the comparable year-ago quarter.
Trailing four quarters
$735.2K
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2025 | $106.5K | -84.9% |
| Sep 30, 2025 | $303.7K | -25.4% |
| Dec 31, 2025 | $303.6K | -57.4% |
| Mar 31, 2026 | $21.5K | -78.9% |
Revenue performance
Revenue fell compared to the immediately preceding quarter. It also decreased relative to the same quarter one year earlier.
Quarterly comparison
The sequential decline was more pronounced than the year-over-year decline. The trailing twelve-month revenue figure reflects the cumulative effect of recent quarterly decreases.
What to watch
The company's cash position may not sustain operations through the end of the calendar year.